TP53, MSH4, and LATS1 Germline Mutations in a Family with Clustering of Nervous System Tumors

Young-Ho Kim , Takashi Ohta , Ji Eun Oh , Florence Le Calvez-Kelm
The American Journal of Pathology 184 ( 9) 2374 -2381

14
2014
Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea

Qi Wang , Kaishi Satomi , Ji Eun Oh , Barbara Hutter
American Journal of Pathology 186 ( 10) 2569 -2576

5
2016
Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas

Jingmei Liu , Huimei Lu , Hiroko Ohgaki , Adrian Merlo
BMC Cancer 9 ( 1) 268 -268

23
2009
Molecular subgroups of adult medulloblastoma: a long-term single-institution study.

Fu Zhao , Hiroko Ohgaki , Lei Xu , Felice Giangaspero
Neuro-oncology 18 ( 7) 982 -990

86
2016
EPID-16PATTERNS OF CARE AND OUTCOME IN GLIOBLASTOMA PATIENTS IN THE CANTON OF ZURICH: A POPULATION-BASED STUDY (2005-2009)

Dorothee Gramatzki , Silvia Dehler , Elisabeth Rushing , Kathrin Zaugg
Neuro-Oncology 17 ( suppl 5) v81.3 -v81

2015
Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.

Kazufumi Sato , Barbara Schäuble , Paul Kleihues , Hiroko Ohgaki
International Journal of Cancer 66 ( 3) 305 -308

63
1996
p53 mutations in sweat gland carcinomas.

Wojciech Biernat , Aurelia Peraud , Leszek Wozniak , Hiroko Ohgaki
International Journal of Cancer 76 ( 3) 317 -320

29
1998
Carcinomas of the renal pelvis associated with smoking and phenacetin abuse:p53 mutations and polymorphism of carcinogen-metabolising enzymes

Pierre-Paul Bringuier , Margaret McCredie , Guido Sauter , Michael Bilous
International Journal of Cancer 79 ( 5) 531 -536

30
1998
Comparative study of p53 gene and protein alterations in human astrocytic tumors.

David N. Louis , Andreas Von Deimling , Richard Y. Chung , Mari-Paz Rubio
Journal of Neuropathology and Experimental Neurology 52 ( 1) 31 -38

205
1993
Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.

Ulrich Sure , Daniela Rüedi , Osamu Tachibana , Yasuhiro Yonekawa
Journal of Neuropathology and Experimental Neurology 56 ( 7) 782 -789

89
1997
Reduced expression of the P2 form of the gap junction protein connexin43 in malignant meningiomas.

Kazufumi Sato , Catherine Gratas , Johannes Lampe , Wojciech Biernat
Journal of Neuropathology and Experimental Neurology 56 ( 7) 835 -839

17
1997
Necrogenesis and Fas/APO-1 (CD95) Expression in Primary (de novo) and Secondary Glioblastomas

Yasuo Tohma , Catherine Gratas , Erwin G Van Meir , Isabelle Desbaillets
Journal of Neuropathology & Experimental Neurology 57 ( 3) 239 -245

69
1998
PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.

Yasuo Tohma , Catherine Gratas , Wojciech Biernat , Aurelia Peraud
Journal of Neuropathology and Experimental Neurology 57 ( 7) 684 -689

230
1998
Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations

Anne Vital , Pierre-Paul Bringuier , Huatao Huang , François San Galli
Journal of Neuropathology and Experimental Neurology 57 ( 11) 1061 -1069

53
1998
Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors

Paul Kleihues , Hiroko Ohgaki
Toxicologic Pathology 28 ( 1) 164 -170

96
2000
749
2018
Genetic Pathways in the Evolution of Gliomas

Hiroko Ohgaki , Paul Kleihues
Humana Press 207 -221

2005
Molecular signatures classify astrocytic gliomas by IDH1 mutation status

Grischa Toedt , Sebastian Barbus , Marietta Wolter , Jörg Felsberg
International Journal of Cancer 128 ( 5) 1095 -1103

69
2011
Contribution of Molecular Biology to the Classification of Low-Grade Diffuse Glioma

Hiroko Ohgaki
Diffuse Low-Grade Gliomas in Adults 61 -72

2013
Molecular classification of low-grade diffuse gliomas.

Young-Ho Kim , Sumihito Nobusawa , Michel Mittelbronn , Werner Paulus
American Journal of Pathology 177 ( 6) 2708 -2714

197
2010